Metabolic Signatures of Cardiac Dysfunction, Multimorbidity, and Post–Transcatheter Aortic Valve Implantation Death
Authors:
- Andrew S. PerryAPAndrew S. Perry
- Shilin ZhaoSZShilin Zhao
- Venkatesh MurthyVMVenkatesh Murthy
- Deepak K. GuptaDGDeepak K. Gupta
- William F. FearonWFWilliam F. Fearon
- Juyong B. KimJKJuyong B. Kim
- Samir KapadiaSKSamir Kapadia
- Dharam J. KumbhaniDKDharam J. Kumbhani
- Linda GillamLGLinda Gillam
- Brian WhisenantBWBrian Whisenant
Open Access
- 4 July 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e029542
Abstract
Background: Studies in mice and small patient subsets implicate metabolic dysfunction in cardiac remodeling in aortic stenosis, but no large comprehensive studies of human metabolism in aortic stenosis with long‐term follow‐up and characterization currently exist. Methods and Results: Within a multicenter prospective cohort study, we used principal components analysis to summarize 12 echocardiographic measures of left ventricular structure and function pre–transcatheter aortic valve implantation in 519 subjects (derivation). We used least absolute shrinkage and selection operator regression across 221 metabolites to define metabolic signatures for each structural pattern and measured their relation to death and multimorbidity in the original cohort and up to 2 validation cohorts (N=543 for overall validation). In the derivation cohort (519 individuals; median age, 84 years, 45% women, 95% White individuals), we identified 3 axes of left ventricular remodeling, broadly specifying systolic function, diastolic function, and chamber volumes. Metabolite signatures of each axis specified both known and novel pathways in hypertrophy and cardiac dysfunction. Over a median of 3.1 years (205 deaths), a metabolite score for diastolic function was independently associated with post–transcatheter aortic valve implantation death (adjusted hazard ratio per 1 SD increase in score, 1.54 [95% CI, 1.25–1.90]; P <0.001), with similar effects in each validation cohort. This metabolite score of diastolic function was simultaneously associated with measures of multimorbidity, suggesting a metabolic link between cardiac and noncardiac state in aortic stenosis. Conclusions: Metabolite profiles of cardiac structure identify individuals at high risk for death following transcatheter aortic valve implantation and concurrent multimorbidity. These results call for efforts to address potentially reversible metabolic biology associated with risk to optimize post–transcatheter aortic valve implantation recovery, rehabilitation, and survival.Keywords
This publication has 80 references indexed in Scilit:
- 2-Aminoadipic acid is a biomarker for diabetes riskJournal of Clinical Investigation, 2013
- The Cardioprotective Effects of Citric Acid and L-Malic Acid on Myocardial Ischemia/Reperfusion InjuryEvidence-Based Complementary and Alternative Medicine, 2013
- Frailty and the Selection of Patients for Destination Therapy Left Ventricular Assist DeviceCirculation: Heart Failure, 2012
- Aortic stenosis and vascular calcifications in alkaptonuriaMolecular Genetics and Metabolism, 2012
- Aspartate and glutamate prevents isoproterenol-induced cardiac toxicity by alleviating oxidative stress in ratsExperimental and Toxicologic Pathology, 2011
- α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic PopulationPLOS ONE, 2010
- MetaboAnalyst: a web server for metabolomic data analysis and interpretationNucleic Acids Research, 2009
- Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injuryJournal of Clinical Investigation, 2008
- N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1American Journal of Physiology-Heart and Circulatory Physiology, 2008
- Quantitative structure–activity relationships for small non-peptide antagonists of CXCR2: Indirect 3D approach using the frontal polygon methodBioorganic & Medicinal Chemistry, 2006